KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,026,873 | -49.2% | 41,557 | -34.8% | 0.00% | -50.0% |
| Q2 2023 | $13,827,149 | +14.5% | 63,764 | -4.1% | 0.00% | 0.0% |
| Q1 2023 | $12,078,083 | +46524.5% | 66,497 | -49.6% | 0.00% | -50.0% |
| Q4 2022 | $25,905 | -99.9% | 131,828 | +9.1% | 0.01% | -20.0% |
| Q3 2022 | $27,186,000 | +63.3% | 120,865 | -8.2% | 0.01% | +66.7% |
| Q2 2022 | $16,646,000 | -27.8% | 131,593 | -27.7% | 0.01% | -14.3% |
| Q1 2022 | $23,069,000 | -12.7% | 181,963 | -9.8% | 0.01% | -12.5% |
| Q4 2021 | $26,417,000 | +18.8% | 201,657 | +10.9% | 0.01% | +14.3% |
| Q3 2021 | $22,245,000 | +82.2% | 181,856 | +69.8% | 0.01% | +75.0% |
| Q2 2021 | $12,209,000 | – | 107,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |